Trials / Recruiting
RecruitingNCT07136025
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Severe asthma is a complex and heterogeneous disease. Patients with severe asthma can present with different types of airway inflammation, and are often accompanied by a variety of comorbidities and risk factors. Identification of potentially modifiable factors affecting prognosis, that is, "treatable characteristics", and individualized bundle management based on these characteristics may help to improve the quality of life of patients with asthma and improve the level of asthma control. Through joint research, this project aims to evaluate the treatable characteristics of asthma in patients with severe asthma in tertiary hospitals across the country, including lung function, fractional exhaled nitric oxide, blood routine, allergen IgE, chest CT, and a detailed questionnaire. The distribution of treatable characteristics of patients with severe asthma and its impact on the quality of life or asthma control level of patients were investigated. For patients with severe asthma, multidisciplinary consultation and shared decision-making were used to establish an individualized bundle management model based on the treatable characteristics of severe asthma. A 6-month randomized parallel controlled clinical trial was conducted to determine whether this model was superior to conventional management in improving the quality of life or asthma control in patients with severe asthma. The implementation of this project will build a new model of individualized management of severe asthma based on treatable characteristics and improve the management level of severe asthma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Individualized cluster management | Individualized cluster management for treatable traits |
| PROCEDURE | Routine asthma treatment | Routine asthma treatment according to current guidelines |
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2029-01-31
- Completion
- 2029-01-31
- First posted
- 2025-08-22
- Last updated
- 2025-08-22
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07136025. Inclusion in this directory is not an endorsement.